Llano DA, Devanarayan V. Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment. J Alzheimers Dis 2021 Jan 25. pii: JAD201420. doi: 10.3233/JAD-201420.
PMID: 33523012